Company / Total Assets
Wave Life Sciences Ltd. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$638.5M
FY2025
5-year range
$146.4M / $638.5M
FY2021-FY2025
Trend
+81.3%
vs FY2024
Sector context
#117 of 214
Health Care
What the data says
At $638M, Wave Life Sciences Ltd.'s total assets ranks #117 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $146M in FY2022 to $638M in FY2025.
Based on SEC 10-K filings.
$638M in FY2025 with a 5-year CAGR of +18.0%.
Improved from $275M to $638M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +63.4%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Sector benchmark
#117 of 214 in Health CareTop 55% of 214This company $638.5M Sector average $7.5B
▼
-91.5% below sector average
Key checks
Key Insights
- Wave Life Sciences Ltd.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +18.0%, indicating consistent growth.
- In FY2025, total assets increased 81.3% year-over-year.
- Ranks #117 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $638.5M | +81.3% |
| FY2024 | $352.2M | +28.1% |
| FY2023 | $274.9M | +87.8% |
| FY2022 | $146.4M | -29.3% |
| FY2021 | $207.0M | -25.9% |
| FY2020 | $279.2M | -1.8% |
| FY2019 | $284.3M | -4.0% |
| FY2018 | $295.9M | +62.7% |
| FY2017 | $181.8M | +10.3% |
| FY2016 | $164.8M | -0.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026